University of Toronto
ARBs reduce left ventricular remodeling and improve function and survival
Published in Law and Health Weekly, July 9th, 2005
According to recent research from Canada, "Angiotensin receptor blockers (ARBs) reduce adverse left ventricular (LV) remodeling and improve LV function and survival when started postmyocardial infarction (MI). ARBs also reduce ventricular arrhythmias during ischemia-reperfusion injury when started pre-MI."
"No information exists regarding their efficacy and safety when started pre-MI and continued peri- and post-MI," said A. Pourdjabbar and colleagues,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Acuity Pharmaceuticals
Deal signed with Intradigm to develop topical drugs for ophthalmic uses - Aphton Corporation
Biotech company appoints Manfred Ruediger as chief operating officer - Avantogen
European patent grant for immune-enhancing adjuvant - European Society for Human Genetics
Geneticists oppose singling out Jewish women in European patent - Exelixis, Inc.
Collaboration to focus on therapeutics for cancer, inflammation, tissue repair - Fred Hutchinson Cancer Research Center, Seattle
Selection during HIV-1 transmission may vary depending on infecting subtype - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
